"Insulin, Isophane" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intermediate-acting INSULIN preparation with onset time of 2 hours and duration of 24 hours. It is produced by crystallizing ZINC-insulin-PROTAMINES at neutral pH 7. Thus it is called neutral protamine Hagedorn for inventor Hans Christian Hagedorn.
| Descriptor ID |
D007336
|
| MeSH Number(s) |
D06.472.699.587.200.300.200 D12.644.548.586.200.300.200
|
| Concept/Terms |
Insulin, Isophane- Insulin, Isophane
- Isophane Insulin
- Neutral Protamine Hagedorn Insulin
- Protamine Hagedorn Insulin
- Hagedorn Insulin, Protamine
- Isophane Insulin, Regular
- Regular Isophane Insulin
- Insulin, NPH
- NPH Insulin
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Isophane".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Isophane".
This graph shows the total number of publications written about "Insulin, Isophane" by people in this website by year, and whether "Insulin, Isophane" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin, Isophane" by people in Profiles.
-
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes. Diabet Med. 2021 01; 38(1):e14378.
-
Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications. Patient. 2018 08; 11(4):377-389.
-
The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications. J Comp Eff Res. 2017 Sep; 6(6):519-527.
-
Comparative effectiveness and safety of different basal insulins in a real-world setting. Diabetes Obes Metab. 2017 08; 19(8):1116-1126.
-
A patient centred approach to basal insulin choice for the management of type 2 diabetes mellitus. J Pak Med Assoc. 2016 Mar; 66(3):360-1.